BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 23202957)

  • 1. NotI microarrays: novel epigenetic markers for early detection and prognosis of high grade serous ovarian cancer.
    Kashuba V; Dmitriev AA; Krasnov GS; Pavlova T; Ignatjev I; Gordiyuk VV; Gerashchenko AV; Braga EA; Yenamandra SP; Lerman M; Senchenko VN; Zabarovsky E
    Int J Mol Sci; 2012 Oct; 13(10):13352-77. PubMed ID: 23202957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic and epigenetic analysis of non-small cell lung cancer with NotI-microarrays.
    Dmitriev AA; Kashuba VI; Haraldson K; Senchenko VN; Pavlova TV; Kudryavtseva AV; Anedchenko EA; Krasnov GS; Pronina IV; Loginov VI; Kondratieva TT; Kazubskaya TP; Braga EA; Yenamandra SP; Ignatjev I; Ernberg I; Klein G; Lerman MI; Zabarovsky ER
    Epigenetics; 2012 May; 7(5):502-13. PubMed ID: 22491060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel tumor suppressor candidates on chromosome 3 revealed by NotI-microarrays in cervical cancer.
    Senchenko VN; Kisseljova NP; Ivanova TA; Dmitriev AA; Krasnov GS; Kudryavtseva AV; Panasenko GV; Tsitrin EB; Lerman MI; Kisseljov FL; Kashuba VI; Zabarovsky ER
    Epigenetics; 2013 Apr; 8(4):409-20. PubMed ID: 23478628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic alterations of chromosome 3 revealed by NotI-microarrays in clear cell renal cell carcinoma.
    Dmitriev AA; Rudenko EE; Kudryavtseva AV; Krasnov GS; Gordiyuk VV; Melnikova NV; Stakhovsky EO; Kononenko OA; Pavlova LS; Kondratieva TT; Alekseev BY; Braga EA; Senchenko VN; Kashuba VI
    Biomed Res Int; 2014; 2014():735292. PubMed ID: 24977159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Novel Epigenetic Markers of Prostate Cancer by NotI-Microarray Analysis.
    Dmitriev AA; Rosenberg EE; Krasnov GS; Gerashchenko GV; Gordiyuk VV; Pavlova TV; Kudryavtseva AV; Beniaminov AD; Belova AA; Bondarenko YN; Danilets RO; Glukhov AI; Kondratov AG; Alexeyenko A; Alekseev BY; Klein G; Senchenko VN; Kashuba VI
    Dis Markers; 2015; 2015():241301. PubMed ID: 26491211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [IDENTIFICATION OF A NEW DIAGNOSTIC MARKERS OF PROSTATIC CANCER, USING NOTI-MICROCHIPS].
    Vozianov SO; Kashuba VI; Grygorenko VM; Gordiyuk VV; Danylets RO; Bondarenko YM; Vikarchuk MV
    Klin Khir; 2016 Apr; (4):54-7. PubMed ID: 27434957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Technology of analysis of epigenetic and structural changes of epithelial tumors genome with NotI-microarrays by the example of human chromosome].
    Pavlova TV; Kashuba VI; Muravenko OV; Yenamandra SP; Ivanova TA; Zabarovskaia VI; Rakhmanaliev ER; Petrenko LA; Pronina IV; Loginov VI; Iurkevich OIu; Kiselev LL; Zelenin AV; Zabarovskiĭ ER
    Mol Biol (Mosk); 2009; 43(2):339-47. PubMed ID: 19425501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter hypermethylation contributes to frequent inactivation of a putative conditional tumor suppressor gene connective tissue growth factor in ovarian cancer.
    Kikuchi R; Tsuda H; Kanai Y; Kasamatsu T; Sengoku K; Hirohashi S; Inazawa J; Imoto I
    Cancer Res; 2007 Aug; 67(15):7095-105. PubMed ID: 17671176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Identification of changes in gene loci potentially associated with cervical cancer using NotI microarrays].
    Kashuba VI; Skripkina IIa; Saraev DV; Gordiiuk VV; Vinnitskaia AB; Tsyba LA; Pogrebnoĭ PV; Blinov VM; Zabarovskiĭ ER; Ryndich AV
    Ukr Biokhim Zh (1999); 2006; 78(2):113-20. PubMed ID: 17100293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a four-gene methylation biomarker panel in high-grade serous ovarian carcinoma.
    Baranova I; Kovarikova H; Laco J; Sedlakova I; Vrbacky F; Kovarik D; Hejna P; Palicka V; Chmelarova M
    Clin Chem Lab Med; 2020 Jul; 58(8):1332-1340. PubMed ID: 32145055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue array analysis of expression microarray candidates identifies markers associated with tumor grade and outcome in serous epithelial ovarian cancer.
    Ouellet V; Guyot MC; Le Page C; Filali-Mouhim A; Lussier C; Tonin PN; Provencher DM; Mes-Masson AM
    Int J Cancer; 2006 Aug; 119(3):599-607. PubMed ID: 16572426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RUNX3 and CAMK2N1 hypermethylation as prognostic marker for epithelial ovarian cancer.
    Häfner N; Steinbach D; Jansen L; Diebolder H; Dürst M; Runnebaum IB
    Int J Cancer; 2016 Jan; 138(1):217-28. PubMed ID: 26175272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic biomarkers in epithelial ovarian cancer.
    Gloss BS; Samimi G
    Cancer Lett; 2014 Jan; 342(2):257-63. PubMed ID: 22245949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel multiple biomarker panel for the early detection of high-grade serous ovarian carcinoma.
    Han C; Bellone S; Siegel ER; Altwerger G; Menderes G; Bonazzoli E; Egawa-Takata T; Pettinella F; Bianchi A; Riccio F; Zammataro L; Yadav G; Marto JA; Penet MF; Levine DA; Drapkin R; Patel A; Litkouhi B; Ratner E; Silasi DA; Huang GS; Azodi M; Schwartz PE; Santin AD
    Gynecol Oncol; 2018 Jun; 149(3):585-591. PubMed ID: 29572027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CGPredictor: a systematic integrated analytic tool for mining and examining genome-scale cancer independent prognostic epigenetic marker panels.
    Cheng WS; Chiang JH
    BMC Syst Biol; 2013; 7 Suppl 6(Suppl 6):S10. PubMed ID: 24565108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of gene expression in stage I serous tumors identifies critical pathways altered in ovarian cancer.
    Chien J; Fan JB; Bell DA; April C; Klotzle B; Ota T; Lingle WL; Gonzalez Bosquet J; Shridhar V; Hartmann LC
    Gynecol Oncol; 2009 Jul; 114(1):3-11. PubMed ID: 19410283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five Hypermethylated MicroRNA Genes as Potential Markers of Ovarian Cancer.
    Braga EA; Loginov VI; Burdennyi AM; Filippova EA; Pronina IV; Kurevlev SV; Kazubskaya TP; Kushlinskii DN; Utkin DO; Ermilova VD; Kushlinskii NE
    Bull Exp Biol Med; 2018 Jan; 164(3):351-355. PubMed ID: 29313235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LRRC3B gene is frequently epigenetically inactivated in several epithelial malignancies and inhibits cell growth and replication.
    Haraldson K; Kashuba VI; Dmitriev AA; Senchenko VN; Kudryavtseva AV; Pavlova TV; Braga EA; Pronina IV; Kondratov AG; Rynditch AV; Lerman MI; Zabarovsky ER
    Biochimie; 2012 May; 94(5):1151-7. PubMed ID: 22321817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and promotor methylation of p73 gene in ovarian epithelial tumors].
    Zhang YL; Guo XR; Shen DH; Cheng YX; Liang XD; Chen YX; Wang Y
    Zhonghua Bing Li Xue Za Zhi; 2012 Jan; 41(1):33-8. PubMed ID: 22455848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylomic Analysis of Ovarian Cancers Identifies Tumor-Specific Alterations Readily Detectable in Early Precursor Lesions.
    Pisanic TR; Cope LM; Lin SF; Yen TT; Athamanolap P; Asaka R; Nakayama K; Fader AN; Wang TH; Shih IM; Wang TL
    Clin Cancer Res; 2018 Dec; 24(24):6536-6547. PubMed ID: 30108103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.